Skip to main content

Endocrine Infertility

  • Chapter
  • First Online:
Book cover Clinical Management of Male Infertility
  • 1441 Accesses

Abstract

This chapter encompasses all spermatogenesis-altering conditions affecting the normal male endocrine balance. Such conditions can be caused by either testicular abnormalities (or other endocrine gland or pituitary-hypothalamus disorders) or the effect of exogenous substances (endocrine disruptors).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Isaia GC, Di Stefano M, Borin F, Gola D, Sciolla A (1997) Inquadramento clinico dell’ipogonadismo maschile. In: Molinatti GM, Fontana D (eds) Andrologia. Fisiopatologia e clinica. Verducci Editore, Roma, pp 157–166

    Google Scholar 

  2. Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG (1978) Prolactin secreting tumours and hypogonadism. N Engl J Med 299:847–852

    Article  PubMed  CAS  Google Scholar 

  3. Rajender S, Monica MG, Walter L, Agarwal A (2011) Thyroid, spermatogenesis, and male infertility. Front Biosci 3:843–855

    Google Scholar 

  4. Krassas GE, Poppe K, Glinoer D (2010) Thyroid function and human reproductive health. Endocr Rev 31:702–755

    Article  PubMed  CAS  Google Scholar 

  5. Shoham Z, Zalel Y, Jacobs HS et al (1994) The role of growth hormone in male infertility. Clin Endocrinol 41:1–5

    Article  CAS  Google Scholar 

  6. Auger J, Kunstmann JM, Czyglik F et al (1995) Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 332:281–285

    Article  PubMed  CAS  Google Scholar 

  7. Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG (2013) The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 62:457–478

    Article  PubMed  CAS  Google Scholar 

  8. Gabrilove JL, Nicolis GL, Sohval AR (1974) The testis in Cushing’s syndrome. J Urol 112:95–99

    PubMed  CAS  Google Scholar 

  9. La Vignera S, Condorelli R, Vicari E, D’Agata R, Calogero AE (2012) Diabetes mellitus and sperm parameters. J Androl 33:145–153

    Article  PubMed  Google Scholar 

  10. Knez J (2013) Endocrine-disrupting chemicals and male reproductive health. Reprod Biomed Online 26:440–448

    Article  PubMed  CAS  Google Scholar 

  11. Sussman EM, Chudnovsky A, Niederberger CS (2008) Hormonal evaluation of the infertile male: has it evolved? Urol Clin North Am 35:147–155

    Article  PubMed  Google Scholar 

  12. Isidori AM, Giannetta E, Lenzi A (2008) Male hypogonadism. Pituitary 11:171–180

    Article  PubMed  Google Scholar 

  13. Chua ME, Escusa KG, Luna S, Tapia LC, Dofitas B, Morales M (2013) Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology 1:749–757

    Article  PubMed  CAS  Google Scholar 

  14. Roth LW, Ryan AR, Meacham RB (2013) Clomiphene citrate in the management of male infertility. Semin Reprod Med 31:245–250

    Article  PubMed  Google Scholar 

  15. Moein MR, Tabibnejad N, Ghasemzadeh J (2012) Beneficial effect of tamoxifen on sperm recovery in infertile men with nonobstructive azoospermia. Andrologia 44(Suppl 1):194–198

    Article  PubMed  Google Scholar 

  16. Schlegel PN (2012) Aromatase inhibitors for male infertility. Fertil Steril 98:1359–1362

    Article  PubMed  CAS  Google Scholar 

  17. Kaminetsky J, Werner M, Fontenot G, Wiehle RD (2013) Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med 10:1628–1635

    Article  PubMed  CAS  Google Scholar 

  18. Paradisi R, Natali F, Fabbri R, Battaglia C, Seracchioli R, Venturoli S (2013) Evidence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility. Andrologia. doi:10.1111/and.12194

    PubMed  Google Scholar 

  19. World Health Organization Task Force on the Diagnosis and Treatment of Infertility (1989) Mesterolone and idiopathic male infertility: a double-blind study. Int J Androl 12:254–264

    Article  Google Scholar 

  20. Comhaire F (1990) Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: a double-blind pilot study. Fertil Steril 54:689–693

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgio D. Piubello .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Piubello, G.D. (2015). Endocrine Infertility. In: Cavallini, G., Beretta, G. (eds) Clinical Management of Male Infertility. Springer, Cham. https://doi.org/10.1007/978-3-319-08503-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-08503-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-08502-9

  • Online ISBN: 978-3-319-08503-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics